| Dr Joel Scott Smith, DDS | |
|
431 Victoria Rd, Newton, KS 67114-5653 | |
| (316) 283-2970 | |
| Not Available |
| Full Name | Dr Joel Scott Smith |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 431 Victoria Rd, Newton, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629007950 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 60223 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joel Scott Smith, DDS 431 Victoria Rd, Newton, KS 67114-5653 Ph: (316) 283-2970 | Dr Joel Scott Smith, DDS 431 Victoria Rd, Newton, KS 67114-5653 Ph: (316) 283-2970 |
News Archive
The National Women's Health Network has petitioned FDA to stop sales of Solvay's Estratest and Breckenridge Pharmaceuticals' Syntest, which are estrogen-testosterone combination therapies used to treat menopause-associated hot flashes, until they are proven safe and effective, Reuters reports.
Boston Scientific Corporation today announced the first implantation of its Vercise™ Deep Brain Stimulation (DBS) System as part of the VANTAGE clinical trial. VANTAGE is a multi-center, prospective trial designed to examine the improvement of motor function in approximately 40 European patients implanted with the Vercise DBS System for the treatment of Parkinson's disease.
Federal guidance issued today aims to reduce the risk that synthetic DNA will be misused deliberately to create dangerous organisms. Screening Framework Guidance for Providers of Synthetic Double-Stranded DNA, issued by the U.S. Department of Health and Human Services, supports national biosecurity goals and balances the promise of synthetic DNA with its potential biosecurity risks.
The National Institutes of Health is expected to award up to $70 million over five years to three physician-scientists to launch the Alzheimer's Clinical Trials Consortium, which will create a network of 35 Alzheimer's disease trial sites across the country with the goal of finding new ways to treat or prevent Alzheimer's.
Enginasion and TransCytos announced today that their collaboration has resulted in a prototype 'transfection' technology that is designed to have a dramatic and positive impact on the drug-research industry.
› Verified 9 days ago
Mackenzie Reed, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 431 Victoria Rd, Newton, KS 67114 Phone: 316-283-2970 | |
Dr. Thomas Joseph Kruse I, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1021 Washington Rd, Suite 200, Newton, KS 67114 Phone: 316-283-4850 | |
Dr. Harold Gregg, Dentist Medicare: Not Enrolled in Medicare Practice Location: 301 N Main St, Suite 104, Newton, KS 67114 Phone: 316-283-2690 | |
Phillip Tippin, Dentist Medicare: Not Enrolled in Medicare Practice Location: 431 Victoria Rd, Newton, KS 67114 Phone: 316-283-2970 | |
Gerald A Vinduska, DDS Dentist Medicare: Medicare Enrolled Practice Location: 215 S Pine St, Newton, KS 67114 Phone: 316-804-7785 Fax: 316-283-1333 | |
Adam Fischer Lukens, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 209 S. Pine St., Newton, KS 67114 Phone: 316-283-6103 Fax: 316-283-0453 | |
Terry L. Davidson, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 120 W 6th St, Newton, KS 67114 Phone: 316-283-0110 Fax: 316-283-0736 |